| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.22B | +15.8% |
| Cost of Revenue | $841.5M | +12.1% |
| R&D Expense | $1.43B | +15.1% |
| SG&A Expense | $466.2M | +0.6% |
| Operating Income | $319.9M | +77.9% |
| Pre-tax Income | $445.9M | +55.0% |
| Income Tax | $29.0M | +101.8% |
| Net Income | $416.9M | -77.6% |
| EPS (Basic) | $0.62 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $969.3M | -14.7% |
| Accounts Receivable | $997.8M | +11.7% |
| Current Assets | $3.56B | +2.0% |
| Total Assets | $5.49B | +2.8% |
| Current Liabilities | $465.5M | +16.9% |
| Total Liabilities | $746.9M | +26.3% |
| Stockholders' Equity | $4.75B | -0.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.28B | +33.1% |
| Capital Expenditures | $32.4M | +31.6% |
| Investing Cash Flow | -$134.5M | +39.2% |
| Financing Cash Flow | -$1.32B | -36.1% |
| Free Cash Flow | $1.25B | +33.2% |
| -77.4% |
| EPS (Diluted) | $0.61 | -77.2% |